You searched for "vascular"
The management of chronic central serous chorioretinopathy
1 February 2017
| Marten E Brelen
|
EYE - Vitreo-Retinal
Central serous chorioretinopathy (CSCR) is a common retinal disease characterised by one or more serous neurosensory detachments. Patients present with acute onset blurring of vision, metamorphopsia and / or central scotomas. The condition is six times more common in men...
The management of antiplatelets and anticoagulation in elective ophthalmic surgery
1 April 2016
| Lee Teak Tan, Jonathan H Norris, Bernard Prendergast
|
EYE - Orbit, EYE - Oculoplastic
Clinical scenario: A 57-year-old gentleman who is scheduled to have Mohs micrographic surgery and reconstruction for a medial canthal basel cell carcinoma (BCC) has been started on aspirin and clopidogrel following a coronary stent three weeks ago. Does the antiplatelet...
The role of aspirin in the treatment of NAION: Benefits and controversies
4 December 2024
| Ali Yagan
|
EYE - Neuro-ophthalmology
Non-arteritic anterior ischaemic optic neuropathy (NAION) is the most common acute optic neuropathy in individuals over 50 with estimated prevalence of 2–10 per 100,000 people, characterised by sudden, unilateral vision loss due to ischaemic injury to the optic nerve head....
Comparison of ketorolac 0.4% and nepafenac 0.1% for the prevention of CMO after phacoemulsification
This is a prospective randomised clinical trial study including patients older than 40 years with age related cataract and normal ophthalmic examination. The patients are randomised into three different groups and the objective of the study is to compare the...
Case report of Leber hereditary optic neuropathy (LHON)
1 October 2016
| Claire Howard
|
EYE - Neuro-ophthalmology
|
Central scotoma, Leberhereditary optic neuropathy, macular hole
This case report presents a 74-year-old male patient who developed LHON, with a previous diagnosis of bilateral macular holes. LHON occurs predominantly in healthy young men and onset in older age ranges increases the likelihood that the patient will have...
Macular oedema after cataract surgery in diabetic patients
1 December 2013
| Lorraine North
|
EYE - Vitreo-Retinal
The authors describe a multi-centre prospective observational study of 293 participants that underwent cataract surgery who all had diabetic retinopathy without definite central-involved macular oedema. Forty-five clinical sites took part throughout the United States. Patients were eligible if there was...
Image Analysis and Modelling in Ophthalmology
1 April 2015
| MN Abdul Karim
|
EYE - Imaging, EYE - Neuro-ophthalmology, EYE - General, EYE - Paediatrics, EYE - Strabismus
Recent advances have revolutionised ophthalmic imaging and helped understand the pathophysiology of ocular diseases and thus help in the diagnosis and management of ocular diseases. The authors of this book have gone through most of the available imaging techniques available...
Review of non-arteritic anterior ischaemic optic neuropathy
1 October 2016
| Chrysostomos D Dimitriou
|
EYE - Neuro-ophthalmology
|
Neuroprotection, optic nerve ischemia, optic nerve vasculature, primate models, rodent models
This article reviews the risk factors, clinical presentation and therapies that have been investigated for non-arteritic anterior ischaemic optic neuropathy (NAAION). Additionally, it provides an update from recent rodent and primate models, offering a new insight into the pathophysiology of...
Ranibizumab safety in pregnancy
1 December 2018
| Sofia Rokerya
|
EYE - Vitreo-Retinal
Vascular endothelial growth factor (VEGF) plays a pivotal role during pregnancy, and systemic anti-VEGF administration during this period should thus be avoided. VEGF is expressed in multiple embryonic and foetal tissues during development, with the highest levels found in the...
Can intravitreal anti-VEGF injections affect corneal nerves?
This was a retrospective case-control study looking at the effect of anti-VEGF injections on corneal nerves (CN). Fifty-seven patients with a history of at least three anti-VEGF injections in one or both eyes and available confocal microscopic imaging were included...Optos announces new ultra-widefield colour image modality, providing additional retinal visualisation to eyecare professionals
Optos, Plc, the leading retinal imaging company, announces it is expanding the optomap® ultra-widefield (UWF™) retinal imaging modalities available with the California FA device to further assist eyecare professionals in disease management and treatment planning.
